R&D Platform
An advanced research and development platform is a key support for promoting global vaccine research and public health projects.
Important Partners
NIDVD, Xiamen University
Xiamen University has achieved remarkable accomplishments in the research and development of vaccines and diagnostic tests. Relying on its strong scientific research strength and multi-disciplinary collaborative efforts, it has jointly developed multiple efficient and safe vaccines and diagnostic tests with Wantai BioPharm, promoting technology transformation and industrial layout.
World Health Organization (WHO)
Wantai Biopharm has a close cooperation with the World Health Organization (WHO). In 2021, the bivalent human papillomavirus vaccine, Cecolin® HPV 16/18, passed the WHO Prequalification, and the TB-IGRA (Tuberculosis Infection T Cell Detection Product) was recommended by the WHO. In 2024, Wantai Biopharm officially signed a long-term supply agreement with the United Nations Office for Project Services (UNOPS).
Alliance of Vaccine Manufacturers of Developing Countries
Established in 2000, this public health alliance is a voluntary coalition of vaccine manufacturers from developing countries, dedicated to enhancing production capabilities through technical exchanges and shared expertise while improving access to quality vaccines in low- and middle-income nations. The alliance now comprises over 40 global members including Wantai BioPharm, extending its impact across 170 countries worldwide.
PATH (Program for Appropriate Technology in Health)
An international non-profit organization established in 1977, focusing on vaccine research and development, disease prevention and control, and technology transfer, helping developing countries improve their health technology capabilities. Its projects include the development of malaria vaccines, the promotion of HPV vaccines, etc., and it supported the HPV vaccine of Wantai Biopharm for passing the WHO Prequalification.
International Vaccine Institute (IVI)
Initiated by the United Nations Development Programme (UNDP) and established in 1997, with its headquarters in Seoul, South Korea. It is committed to developing affordable vaccines for developing countries, such as vaccines against cholera, typhoid fever, and Hepatitis E. It has carried out cooperation with Wantai BioPharm in the international clinical trials of the Hepatitis E vaccine.
National Vaccine Institute of Thailand
The core institution for vaccine research and development and policy in Thailand, responsible for coordinating the national immunization program and international cooperation. Its actions include joining the Covax program to ensure the supply of COVID-19 vaccines, cooperating with Wantai BioPharm in HPV vaccines, and participating in the local research and development of vaccines such as the dengue fever vaccine.
Gates Foundation
The Gates Foundation is a global philanthropic organization that focuses on vaccine research and development and delivery to prevent diseases and improve global health. Wantai BioPharm has cooperated with the Gates Foundation in multiple fields. Currently, the two parties are collaborating on international clinical trials related to products, and the relevant research is being promoted in multiple countries and regions. In addition, both sides are actively exploring in-depth cooperation in other aspects to improve the accessibility of vaccine products.
Our Awards
Wantai BioPharm has led over 90 national and provincial-level major initiatives, including National Key R&D Programs and Mega Science Projects. Our scientific contributions have earned nearly 20 prestigious awards at both state and provincial levels, most notably the Second Class Prize of China's National Science and Technology Progress Award and the coveted Chinese Patent Gold Award.
Second Prize of the National Technological Invention Award-Hepatitis E Test
Second Prize of the National Science and Technology Progress Award-Third-generation AIDS Test
China Patent Gold Award-Hepatitis E Vaccine
First Prize of the Beijing Science and Technology Award-Fourth-generation AIDS Test
Second Prize of the Beijing Science and Technology Award-Quality Control Products and Reference Materials
Outstanding Scientific and Technological Achievement Collective Award-Vaccine Platform
First Prize of the Fujian Provincial Science and Technology Progress Award-Hand, Foot and Mouth Disease Test
Second Prize of the Fujian Provincial Science and Technology Progress Award-Influenza Test
First Prize of the Fujian Provincial Science and Technology Award-HPV Vaccine
Major Progress in Chinese Medicine - HIV Self-test by Urine
Filing Number:（京）网药械信息备字（2023）第00164号
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement